Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Treatment Options in Colorectal Liver Metastases: Hepatic Arterial Infusion.

Zervoudakis A, Boucher T, Kemeny NE.

Visc Med. 2017 Mar;33(1):47-53. doi: 10.1159/000454693. Epub 2017 Feb 3. Review.

2.

Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis.

Groot Koerkamp B, Sadot E, Kemeny NE, Gönen M, Leal JN, Allen PJ, Cercek A, DeMatteo RP, Kingham TP, Jarnagin WR, D'Angelica MI.

J Clin Oncol. 2017 Jun 10;35(17):1938-1944. doi: 10.1200/JCO.2016.71.8346. Epub 2017 Apr 20.

PMID:
28426374
3.

Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy.

Kemeny NE, Chou JF, Boucher TM, Capanu M, DeMatteo RP, Jarnagin WR, Allen PJ, Fong YC, Cercek A, D'Angelica MI.

J Surg Oncol. 2016 Apr;113(5):477-84. doi: 10.1002/jso.24189. Epub 2016 Feb 2.

4.

Hepatic resection, hepatic arterial infusion pump therapy, and genetic biomarkers in the management of hepatic metastases from colorectal cancer.

McAuliffe JC, Qadan M, D'Angelica MI.

J Gastrointest Oncol. 2015 Dec;6(6):699-708. doi: 10.3978/j.issn.2078-6891.2015.081. Review.

5.

Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone.

Konstantinidis IT, Groot Koerkamp B, Do RK, Gönen M, Fong Y, Allen PJ, D'Angelica MI, Kingham TP, DeMatteo RP, Klimstra DS, Kemeny NE, Jarnagin WR.

Cancer. 2016 Mar 1;122(5):758-65. doi: 10.1002/cncr.29824. Epub 2015 Dec 22.

6.

Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver.

Said R, Kurzrock R, Naing A, Hong DS, Fu S, Piha-Paul SA, Wheler JJ, Janku F, Kee BK, Bidyasar S, Lim J, Wallace M, Tsimberidou AM.

Invest New Drugs. 2015 Aug;33(4):911-20. doi: 10.1007/s10637-015-0251-5. Epub 2015 May 21.

7.

Colorectal hepatic metastasis: Evolving therapies.

Macedo FI, Makarawo T.

World J Hepatol. 2014 Jul 27;6(7):453-63. doi: 10.4254/wjh.v6.i7.453. Review.

8.

Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statement.

Karanicolas PJ, Metrakos P, Chan K, Asmis T, Chen E, Kingham TP, Kemeny N, Porter G, Fields RC, Pingpank J, Dixon E, Wei A, Cleary S, Zogopoulos G, Dey C, D'Angelica M, Fong Y, Dowden S, Ko YJ.

Curr Oncol. 2014 Feb;21(1):e129-36. doi: 10.3747/co.21.1577.

9.

Hepatic arterial infusion pump chemotherapy for colorectal liver metastases: an old technology in a new era.

Ko YJ, Karanicolas PJ.

Curr Oncol. 2014 Feb;21(1):e116-21. doi: 10.3747/co.21.1592.

10.

Therapeutic effect and tolerability of gelatin sponge particle-mediated chemoembolization for colorectal liver metastases: a retrospective study.

Li C, Zhang Y, Zhou J, Zhao G, Tang S.

World J Surg Oncol. 2013 Sep 9;11:222. doi: 10.1186/1477-7819-11-222.

11.

NF-κB pathway in colitis-associated cancers.

Viennois E, Chen F, Merlin D.

Transl Gastrointest Cancer. 2013 Jan 1;2(1):21-29.

12.

Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements.

Abdalla EK, Bauer TW, Chun YS, D'Angelica M, Kooby DA, Jarnagin WR.

HPB (Oxford). 2013 Feb;15(2):119-30. doi: 10.1111/j.1477-2574.2012.00597.x.

13.

What is the potential role of hepatic arterial infusion chemo-therapy in the current armamentorium against colorectal cancer.

Kanat O, Gewirtz A, Kemeny N.

J Gastrointest Oncol. 2012 Jun;3(2):130-8. doi: 10.3978/j.issn.2078-6891.2011.025.

14.

Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response.

Yopp AC, Schwartz LH, Kemeny N, Gultekin DH, Gönen M, Bamboat Z, Shia J, Haviland D, D'Angelica MI, Fong Y, DeMatteo RP, Allen PJ, Jarnagin WR.

Ann Surg Oncol. 2011 Aug;18(8):2192-9. doi: 10.1245/s10434-011-1570-1. Epub 2011 Feb 1.

15.

Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer.

Kemeny NE, Jarnagin WR, Capanu M, Fong Y, Gewirtz AN, Dematteo RP, D'Angelica MI.

J Clin Oncol. 2011 Mar 1;29(7):884-9. doi: 10.1200/JCO.2010.32.5977. Epub 2010 Dec 28.

16.

A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver.

Tsimberidou AM, Fu S, Ng C, Lim JA, Wen S, Hong D, Wheler J, Bedikian AY, Eng C, Wallace M, Camacho LH, Kurzrock R.

Cancer. 2010 Sep 1;116(17):4086-94. doi: 10.1002/cncr.25277.

Supplemental Content

Support Center